Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Elanco Animal Health Incorporated

ELANNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$24.39
$-0.81(-3.23%)
U.S. Market is Open • 14:24

Elanco Animal Health Incorporated (ELAN) Stock Overview

Explore Elanco Animal Health Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.4B
P/E Ratio343.27
EPS (TTM)$0.07
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$24.50
3 Months$30.58
1 Year Target$27.07

ELAN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Elanco Animal Health Incorporated (ELAN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $27.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 343.27 and a market capitalization of 12.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.91%
5-Day Change
0.48%
1-Month Change
3.35%
3-Month Change
17.56%
6-Month Change
43.01%
Year-to-Date (YTD) Change
10.88%
1-Year Change
124.35%
3-Year Change
114.89%
5-Year Change
-18.35%
All-Time (Max) Change
-30.64%

Contact Information

877 352 6261
2500 Innovation Way, Greenfield, IN, 46140

Company Facts

90,000 Employees
IPO DateSep 20, 2018
CountryUS
Actively Trading

Frequently Asked Questions